Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of impact of zostavax vaccination on T-cell accumulation and cutaneous gene expression in the skin of older humans after varicella zoster virus antigen-specific challenge

Trial Profile

Study of impact of zostavax vaccination on T-cell accumulation and cutaneous gene expression in the skin of older humans after varicella zoster virus antigen-specific challenge

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2018

At a glance

  • Drugs Varicella zoster virus vaccine (Primary)
  • Indications Herpes zoster; Varicella zoster virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2018 New trial record
    • 22 Sep 2018 Results published in the Journal of Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top